| 1 |
Oken MM，Creech RH，Tormey DC，et al.Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol，1982，5：649-655.
|
| 2 |
Yamada R，Sato M，Kawabata M，et al.Hepatic artery embolization in 120 patients with unresectable hepatoma.Radiology，1983，148：397-401.
|
| 3 |
林贵，王建华，顾正明，等.肝动脉化疗栓塞治疗晚期肝癌的疗效和影响因素.中华放射学杂志，1992，26：311-315.
|
| 4 |
Kan Z，Ivancev K，Lunderquist A，et al.In vivo microscopy of hepatic tumors in animal models：a dynamic investigation of blood supply to hepatic metastases.Radiology，1993，187：621-626.
|
| 5 |
Yan ZP，Lin G，Zhao HY，et al.An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer.Cancer，1993，72：3210-3215.
|
| 6 |
汪阳，胡国栋.肝节段动脉栓塞治疗原发性肝癌.中华放射学杂志，1996，30：85-89.
|
| 7 |
程留芳，王志强.240例不能手术切除的原发性肝癌肝动脉化疗栓塞生存期分析.中华肿瘤杂志，1996，18：362-364.
|
| 8 |
汤钊猷.肝癌临床研究的进展与21世纪的展望.上海医科大学学报，1997，24：323-325.
|
| 9 |
肖恩华，胡国栋，刘鹏程，等.化疗栓塞后肝细胞癌细胞凋亡的研究.中华放射学杂志，1999，33：153-155.
|
| 10 |
Lim HK，Han JK.Hepatocellular carcinoma：evaluation of therapeutic response to interventional procedures.Abdom Imaging，2002，27：168-179.
|
| 11 |
刘璐，滕皋军.32P-玻璃微球介入治疗肝细胞肝癌的临床初步应用.核技术，2000，23：316-322.
|
| 12 |
Bruix J，Llovet JM.Prognostic prediction and treatment strategy in hepatocellular carcinoma.Hepatology，2002，35：519-524.
|
| 13 |
范卫君，赵明，吴沛宏，等.经皮射频消融术在肝脏肿瘤治疗中的临床价值.中华放射学杂志，2002，36：313-316.
|
| 14 |
Maluccio M，Covey AM，Gandhi R，et al.Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.J Vasc Interv Radiol，2005，16：955-961.
|
| 15 |
张学彬，王建华，颜志平，等.门静脉支架置入联合动脉化疗栓塞和序贯门静脉放疗治疗肝癌合并门静脉主干癌栓.中华放射学杂志，2008，42：1311-1315.
|
| 16 |
Llovet JM，Burroughs A，Bruix J.Hepatocellular carcinoma.Lancet，2003，362：1907-1917.
|
| 17 |
周泽健，罗鹏飞，邵培坚，等.介入治疗后38例中晚期肝癌患者生存5年以上的因素分析.中华放射学杂志，2002，36：792-796.
|
| 18 |
董宝玮，梁萍，于晓玲，等.超声引导经皮微波治疗原发性肝癌远期疗效评价.中华肿瘤杂志，2002，24：282-284.
|
| 19 |
卢伟，李彦豪，李祖国，等.小剂量和常规剂量化疗药物经导管动脉内化疗栓塞后肝癌细胞坏死及凋亡的比较研究.中华放射学杂志，2003，37：232-236.
|
| 20 |
Llovet JM，Real MI，Montana X，et al.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma：a randomised controlled trial.Lancet，2002，359：1734-1739.
|
| 21 |
Llovet JM，Bruix J.Systematic review of randomized trials for unresectable hepatocellular carcinoma：chemoembolization improves survival.Hepatology，2003，37：429-442.
|
| 22 |
Brown DB，Fundakowski CE，Lisker-Melman M，et al.Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.J Vasc Interv Radiol，2004，15：1209-1218.
|
| 23 |
Ohmoto K，Yoshioka N，Tomiyama Y，et al.Thermal ablation therapy for hepatocellular carcinoma：comparison between radiofrequency ablation and percutaneous microwave coagulation therapy.Hepatogastroenterology，2006，53：651-654.
|
| 24 |
Molinari M，Kachura JR，Dixon E，et al.Transarterial chemoembolisation for advanced hepatocellular carcinoma：results from a North American cancer centre.Clin Oncol（R Coll Radiol），2006，18：684-692..
|
| 25 |
Jang JW，Choi JY，Bae SH，et al.A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemolipiodolization.Hepatology，2006，43：233-240.
|
| 26 |
Takayasu K，Arii S，Ikai I，et al.Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.Gastroenterology，2006，131：461-469.
|
| 27 |
El-Serag HB，Rudolph KL.Hepatocellular carcinoma：epidemiology and molecular carcinogenesis.Gastroenterology，2007，132：2557-2576.
|
| 28 |
郭栋，肖恩华.不同化疗栓塞方式对肝细胞癌血管生成的影响.中华放射学杂志，2007，41：1369-1373.
|
| 29 |
Llovet JM，Di Bisceglie AM，Bruix J，et al.Design and endpoints of clinical trials in hepatocellular carcinoma.J Natl Cancer Inst，2008，100：698-711.
|
| 30 |
周大勇，王建华，刘嵘，等.肝癌化疗栓塞术后残癌和癌旁组织血管内皮生长因子受体2及其磷酸化状态的表达水平.中华放射学杂志，2008，42：406-409.
|
| 31 |
Forner A，Ayuso C，Varela M，et al.Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma.Cancer，2009，115：616-623.
|
| 32 |
Matsui O，Miyayama S，Sanada J，et al.Interventional oncology：new options for interstitial treatments and intravascular approaches：superselective TACE using iodized oil for HCC：rationale，technique and outcome.J Hepatobiliary Pancreat Sci，2010，17：407-409.
|
| 33 |
Dufour JF，Hoppe H，Heim MH，et al.Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma：results of a phase I study.Oncologist，2010，15：1198-1204.
|
| 34 |
Spira D，Fenchel M，Lauer UM，et al.Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib.Acad Radiol，2010，18：89-96.
|
| 35 |
Lencioni R，Llovet JM.Modified RECIST（mRECIST）assessment for hepatocellular carcinoma.Semin Liver Dis，2010，30：52-60.
|
| 36 |
Qu XD，Chen CS，Wang JH，et al.The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma.BMC Cancer，2012，12：263.
|
| 37 |
D'Amico G，Garcia-Tsao G，Pagliaro L.Natural history and prognostic indicators of survival in cirrhosis：a systematic review of 118 studies.J Hepatol，2006，44：217-231.
|
| 38 |
Llovet JM，Ricci S，Mazzaferro V，et al.Sorafenib in advanced hepatocellular carcinoma.N Engl J Med，2008，359：378-390.
|
| 39 |
Cheng AL，Kang YK，Chen Z，et al.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma：a phase Ⅲ randomised，double-blind，placebo-controlled trial.Lancet Oncol，2009，10：25-34.
|
| 40 |
中国抗癌协会肝癌专业委员会.原发性肝癌规范化诊治专家共识.临床肿瘤学杂志，2009，14：259-269.
|
| 41 |
Bruix J，Sherman M，Llovet JM，et al.Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona-2000 EASL conference.J Hepatol，2001，35：421-430.
|
| 42 |
Bruix J，Sherman M.Management of hepatocellular carcinoma：an update.J Hepatol，2010，53：1020-1022.
|
| 43 |
Chen PJ，Furuse J，Han KH，et al.Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia：experts'opinion.Liver Int，2010，30：1427-1438.
|
| 44 |
Rampone B，Schiavone B，Martino A，et al.Current management strategy of hepatocellular carcinoma.World J Gastroenterol，2009，15：3210-3216.
|
| 45 |
Giglia JL，Antonia SJ，Berk LB，et al.Systemic therapy for advanced hepatocellular carcinoma：past，present，and future.Cancer Control，2010，17：120-129.
|